Advancing Genetic Testing in Reproductive Medicine for Healthy Pregnancies

January 17, 2025
Advancing Genetic Testing in Reproductive Medicine for Healthy Pregnancies

The subject of advanced genetic testing in reproductive medicine is a multi-faceted discussion centered on improving the chances of healthy pregnancies in families at risk of genetic disorders. The article explores various techniques and innovations in genetic testing, their applications, and the continuous efforts by researchers and medical professionals to enhance these methodologies and make them more widely accessible.

At the heart of this narrative is the story of Bojana Mirosavljević, a mother who faced the tragedy of losing her eldest daughter, Zoja, to CLN2, a devastating genetic disorder caused by malfunctioning TPP1 genes. Her subsequent journey through 27 rounds of in-vitro fertilization (IVF) and the successful use of preimplantation genetic testing (PGT) to ensure the birth of her two healthy daughters is a poignant testament to the impact of advanced genetic testing.

The Evolution of Preimplantation Genetic Testing (PGT)

The Development and Application of PGT

Preimplantation Genetic Testing (PGT), honed since its inception in the 1990s, allows for the analysis of embryos at early stages to detect genetic abnormalities before implantation. This process was crucial for Mirosavljević, as it enabled doctors to select embryos free from genetic flaws like those causing CLN2. The successful application of PGT in her case underscores its potential to save families from the heartbreak of genetic diseases and significantly improve outcomes for at-risk couples.

Broader contexts, such as infertility in Europe, are also a growing concern that affects one in six couples, with higher rates in eastern and southern regions. The urgency for widespread access to reproductive technologies like PGT is highlighted against this backdrop. However, a stark disparity exists across Europe; countries like Spain, the Netherlands, and the UK lead in comprehensive PGT services, while others like Ireland, Greece, and Germany lag behind. This disparity reflects the need for equal access to these advanced reproductive options, ensuring all families have the opportunity for healthy pregnancies.

Collaborative Efforts to Expand PGT Access

One of the crucial themes in expanding access to PGT involves the collaborative efforts among European countries. Researchers and doctors, supported by EU initiatives, are working diligently to expand the availability of PGT and other reproductive services. This collective goal is epitomized by projects like NESTOR, an EU-funded initiative co-led by Greek fertility specialist Dr. Aspasia Destouni and Estonian molecular biologist Dr. Ants Kurg. NESTOR aims to create a network of researchers from Greece, Estonia, and the Netherlands to translate laboratory discoveries into practical solutions, improve PGT and non-invasive prenatal testing (NIPT), and enhance female reproductive health and fertility prediction methods.

Another inspiration within this collaborative framework is Estonia’s model, particularly with the establishment of the Estonian Biobank. The biobank collects and stores genetic and health data from a significant portion of the population to support research and personalized medicine, advancing reproductive medicine significantly. Comprehensive data collection exemplified by such initiatives fuels scientific progress and public health improvements, addressing the urgent need for improved reproductive health services across Europe.

Estonia’s Model and the Role of Biobanks

The Establishment and Impact of the Estonian Biobank

Estonia’s model serves as an inspiration within the collaborative framework of advancing reproductive medicine. The establishment of the Estonian Biobank, collecting and storing genetic and health data from a significant population segment, supports research and personalized medicine. This biobank exemplifies how comprehensive data collection can fuel scientific progress and public health improvements, proving crucial in the journey toward better reproductive healthcare.

The success of Estonia’s fertility research efforts can be traced back to the EU’s Widening initiative, aiming to transfer expertise from established research centers to those in less advanced countries. This initiative’s collaborative nature has led to valuable networks between research teams, significantly impacting Estonia and Greece, initially classified as Widening countries. The transfer of knowledge and technologies through such networks has undeniably contributed to their advancements in reproductive medicine, facilitating more robust and accessible healthcare services.

The WIDENLIFE Project and Its Contributions

A defining moment in Estonia’s progress was the establishment of a clinic at the University of Tartu in 2016. This clinic, set up in close collaboration with fertility experts from KU Leuven in Belgium and the University of Oxford, UK, exemplifies the tangible outcomes of international collaboration. The WIDENLIFE project, an offshoot of the Widening initiative, played a pivotal role by enhancing the availability and affordability of pre-implantation testing and prenatal genetic testing in Estonia.

Professor Kurg, a central figure in these advancements, highlights that prior to WIDENLIFE, genetic testing was both limited and costly in Estonia, with samples needing to be sent abroad, causing delays. The project allowed Estonia to develop its own testing infrastructure, significantly improving the speed and accessibility of these critical services. Utilizing single-cell analysis and software algorithms, the system developed by WIDENLIFE enhances the likelihood of successful embryo implantation and development, thus aiding IVF treatments and profoundly impacting the nation’s reproductive health landscape.

Addressing Age-Related Fertility Challenges

The Impact of Age on Fertility

As women age, fertility naturally declines, posing challenges for those seeking to conceive later in life. Advanced genetic testing and reproductive technologies can help mitigate some of these challenges by identifying and selecting viable embryos, thereby increasing the chances of successful pregnancies. However, these technologies must be made accessible to all who need them, regardless of geographic location or financial status, to ensure equitable reproductive healthcare. Collaborative efforts and continued research are essential in advancing these technologies and making them available to a broader population, ultimately improving reproductive outcomes for many.

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later